ChordNews
← All news

Takeda Pharmaceutical reports non-GAAP EPS of ¥308.00 and revenue of ¥2407B, and upgrades its FY 2026 outlook

By ChordNews · First written

Comments 0

Summary

Takeda Pharmaceutical reported non-GAAP earnings per share of ¥308.00 and revenue of ¥2407B, and upgraded its FY 2026 outlook, according to a Seeking Alpha breaking-news item. The item's summary was empty, so the available reporting gives no further detail on the results or on what changed in the outlook.

This continues an earlier story: Canon reports GAAP EPS of $1.83 and revenue of $21.87M, updates FY2026 outlook

Timeline

  1. Seeking Alpha

    Source ↗

    Seeking Alpha reports that Takeda Pharmaceutical posted non-GAAP EPS of ¥308.00 and revenue of ¥2407B, and upgraded its FY 2026 outlook.

Comments

No comments yet.

    to like and comment.

    © 2026 ChordNews